Aarti Pharmalabs Profit & Loss Annual

BSE: 543748 | NSE: AARTIPHARM | ISIN: INE0LRU01027 | Sector: Biotechnology & Drugs

826.90 +1.90 (0.23%)Updated : 11 Sep 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	1,524.15	1,737.61	1,539.80	1,665.33
Other Net	7.61	0.04	0.60	-1.23
Diluted Weighted Average Shares	9.07	9.06	9.06	9.06
Depreciation/ Amortization	104.34	86.90	73.24	62.54
Operating Income	295.29	377.47	312.81	279.90
Net Income	174.71	272.40	216.90	193.49
Income Availableto Com Excl Extra Ord	174.71	272.40	216.90	193.49
Other Operating Expenses Total	10.33	0.00	0.00	3.65
Net Income Before Taxes	232.92	360.69	300.49	260.77
Net Income After Taxes	174.71	272.40	216.90	193.49
Income Availableto Com Incl Extra Ord	174.71	272.40	216.90	193.49
Costof Revenue Total	834.83	1,127.88	1,020.72	1,169.76
Gross Profit	984.61	987.20	831.89	775.48
Interest Inc( Exp) Net- Non- Op Total	-69.97	-16.82	-12.94	-17.45
Unusual Expense( Income)	2.79	-	-	0.00
Diluted Net Income	174.71	272.40	216.90	193.49
DPS- Common Stock Primary Issue	3.50	5.00	3.00	-
Provisionfor Income Taxes	58.21	88.28	83.59	67.28
period Type	-	-	-	-
Net Income Before Extra Items	174.71	272.40	216.90	193.49
Total Revenue	1,819.44	2,115.07	1,852.61	1,945.23
period Length	12.00	12.00	12.00	12.00
Revenue	1,819.44	2,115.07	1,852.61	1,945.23
Selling/ General/ Admin Expenses Total	539.01	489.99	437.48	415.43
Diluted Normalized EPS	19.49	30.05	23.93	21.39
Research Development	32.85	32.83	8.37	13.96
Diluted EPS Excluding Extra Ord Items	19.25	30.06	23.93	21.35
Gain( Loss)on Saleof Assets	-	0.01	0.02	-0.45

*All figures in crores except per share values

272.00+6.05(2.27%)

1,260.00+20.50(1.65%)

11,053.00+157.00(1.44%)

1,196.80-29.75 (-2.43%)

185.95-2.60 (-1.38%)

Related News